Onemednet CORP

OneMedNet Corporation announced its 2026 Annual Meeting of Stockholders will be held on September 18, 2026, with a record date of August 11, 2026, and updated deadlines for shareholder proposals and director nominations.

OneMedNet Corporation has entered into a standby equity purchase agreement with YA II PN, Ltd. allowing for up to $25 million in potential capital raises over 36 months.

OneMedNet Corporation has been notified by Nasdaq of non-compliance with the minimum $1.00 bid price requirement.

OneMedNet Corporation's 2025 Annual Meeting saw stockholders elect two Class II Directors and ratify Withum Smith+Brown, PC as its independent auditor, alongside a Compensation Committee appointment.

Jair Clarke, a director at OneMedNet Corporation, will not stand for re-election at the company's 2025 Annual Meeting of Stockholders.

OneMedNet Corporation announced it has regained compliance with Nasdaq's minimum bid price requirement, resolving a previous listing issue.

OneMedNet Corporation reported a net loss of $0.7 million for Q3 2025, narrowing from the prior year, driven by a strategic pivot to web imaging revenue and significant debt restructurings, while facing substantial doubt about its ability to continue as a going concern.

OneMedNet Corporation reported net income for Q2 2025 driven by debt restructuring gains, despite a significant overall revenue decrease and ongoing going concern doubts.

OneMedNet Corporation's Q1 2025 revenue decreased by 45% year-over-year as the company transitions away from its BEAM platform and focuses on iRWD sales.

OneMedNet Corporation's Q3 2024 results reveal a net loss and declining revenue, alongside strategic shifts and financial restructuring efforts.

OneMedNet Corporation's Q2 2024 results show a revenue increase driven by web imaging, offset by a decrease in subscription revenue, alongside significant changes in financial structure and management.

OneMedNet Corporation's first quarter 2024 results show a 24% increase in revenue compared to the same period last year, driven by growth in both subscription and web imaging services.

OneMedNet Corporation filed an amendment to its 2025 Annual Report to include required Part III disclosures regarding governance and executive compensation.

OneMedNet Corporation reports a net loss of $10.1 million for 2024 and expresses substantial doubt about its ability to continue as a going concern.

OneMedNet Corporation restated its 2023 and 2022 financial statements due to accounting errors and the suspension of its previous auditor, BF Borgers CPA PC.

OneMedNet Corporation's 10-K filing outlines its business model, financial performance, and future strategies in the clinical imaging and real-world data market.

OneMedNet Corp CEO Aaron Green reported a significant purchase of company common stock on June 23, 2026.

OneMedNet Corp reports a significant stock purchase by Chief Medical Officer Jeffrey Yu, indicating insider confidence in the company's prospects.

OneMedNet Corp director Jeffrey Yu invested $100,000 in the company and acquired 172,414 common shares, while disclaiming beneficial ownership of shares held in a trust for his children.

OneMedNet Corp CEO Aaron Green has acquired a significant number of company shares through multiple transactions in June 2026.

OneMedNet Corp director Thomas Kosasa acquired 158,730 shares through a subscription agreement for $100,000.

Director Thomas Kosasa acquired 268,817 shares of OneMedNet Corp for $250,000 via a subscription agreement.

OneMedNet Corporation has filed a definitive proxy statement with the SEC, initiating the formal solicitation of shareholder votes.

OneMedNet Corporation announced its 2025 Annual Meeting of Stockholders to be held virtually on December 17, 2025, to elect directors and ratify its independent accounting firm.

OneMedNet Corporation has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.

OneMedNet Corporation will hold its 2024 Annual Meeting of Stockholders virtually on December 19, 2024, to elect directors and ratify the appointment of its independent auditor.

OneMedNet Corporation has filed an S-1/A amendment to register the resale of up to 11,680,535 shares of common stock by selling stockholders, while also addressing Nasdaq's minimum bid price non-compliance.

OneMedNet Corporation has filed a registration statement with the SEC to permit the resale of up to 11,680,535 shares of its common stock by selling stockholders.

A healthcare software company is seeking to register millions of shares for public and secondary offerings while grappling with significant financial losses, a going concern warning, and multiple Nasdaq listing deficiencies.

OneMedNet Corporation, a healthcare software company, reported continued significant net losses and a substantial accumulated deficit, leading its auditors to express substantial doubt about its ability to continue as a going concern, while simultaneously facing multiple Nasdaq listing compliance issues and pursuing significant equity and debt financing.

OneMedNet Corporation has amended its pre-funded warrant and securities purchase agreements with Off the Chain, LP, and filed a registration statement for the resale of common stock and warrants.

Data Knights Acquisition Corp. outlines the terms and conditions for warrants, including exercise price, duration, transferability, and redemption rights, in an amended warrant agreement.

Discovery Capital Management and affiliates have reported a complete divestment of their beneficial ownership in OneMedNet Corporation.

TD Securities (USA) LLC has disclosed a 6.2% beneficial ownership stake in OneMedNet Corporation, primarily through exercisable warrants.

TD Securities (USA) LLC, as successor to Cowen and Company, LLC, has disclosed a beneficial ownership of 8.9% in OneMedNet Corporation, primarily through warrants.